{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "iolanda Vendrell"}, {"accession": "MS:1000589", "name": "contact email", "value": "iolanda.vendrell@oncology.ox.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "CRUK-MRC Oxford Institute for Radiation Oncology, Oxford University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Eric O'Neil"}, {"accession": "MS:1000589", "name": "contact email", "value": "eric.oneill@oncology.ox.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Oncology, University of Oxford, Oxford, Oxfordshire, OX3 7DQ, UK"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/1_MST2_untr_1_F307741.xml"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/5_MST2_untr_2_F307742.xml"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/9_MST2_Untr_3_F307744.xml"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_1_MST2_Untr_1_1ul.mgf"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_5_MST2_Untr_2.mgf"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_9_MST2_Untr_3.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_1_MST2_Untr_1_1ul.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_5_MST2_Untr_2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517/QE660_MSQ708_DafniPefani_20160805_9_MST2_Untr_3.raw"}], "description": "Nuclear actin participates in many essential cellular processes including gene transcription, chromatic remodelling and mRNA processing. Actin shuttles into and out the nucleus through the action of dedicated transport receptors importin-9 and exportin-6, but how this transport is regulated remains unclear. Here we show that RASSF1A is a novel regulator of actin nucleocytoplasmic trafficking and is required for the active maintenance of nuclear actin levels through supporting binding of exportin-6 (XPO6) to RAN GTPase. RASSF1A (Ras association domain family 1 isoform A) is a tumor suppressor gene frequently silenced by promoter hypermethylation in all major solid cancers. Specifically, we demonstrate that endogenous RASSF1A localizes to the nuclear envelope (NE) and is required for nucleo-cytoplasmic actin transport and the concomitant regulation of Myocardin-related transcription factor A (MRTF-A), a coactivator of the transcription factor serum response factor (SRF). The RASSF1A/RAN/XPO6/nuclear actin pathway is aberrant in cancer cells where RASSF1A expression is lost and correlates with reduced MTRF/SRF activity leading to cell adhesion defects. Taken together, we have identified a previously unknown mechanism by which the nuclear actin pool is regulated and uncovered a previously unknown link of RASSF1A and MTRF/SRF in tumor suppression.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD011517"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD011517"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD011517"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "RASSF1A, MST2, nuclear envelope, nuclear actin, nucleocytoplasmic shuttling, nuclear export, exportin-6, SRF, MRTF-A"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biological"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}, {"accession": "MOD:00400", "name": "deamidated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "31175105"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Chatzifrangkeskou M, Pefani DE, Eyres M, Vendrell I, Fischer R, Pankova D, O'Neill E. RASSF1A is required for the maintenance of nuclear actin levels. EMBO J. 2019"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "RASSF1A IS REQUIRED FOR THE MAINTENANCE OF NUCLEAR ACTIN LEVELS"}